FIRST: Intas Pharma launches Romiplostim to treat chronic ITP in India Medical Dialogues Bureau12 July 2019 6:18 AM GMTRomiplostim is one of the most efficacious agents with proven long-term benefits in chronic ITP, a release here said.Mumbai: Pharma Major, Intas...
Over Rs 74 crore fine on Himalaya, Intas Pharma, 2 Chemist Associations for anti-competitive trade practices Medical Dialogues Bureau8 Jun 2019 9:05 AM GMTAs per the CCI order, Himalaya Drug was fined Rs 18.59 crore while its three senior officials were fined a total of nearly Rs 4 lakh. Besides, Intas...
Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate Meghna A Singhania11 April 2019 5:20 AM GMTMumbai: In a move that will provide relief to cancer patients, drugmaker Intas Pharmaceuticals has recently announced the launch of Trastuzumab...